MX2020013340A - Composicion afrodisiaca y manejo de la disfuncion sexual masculina. - Google Patents
Composicion afrodisiaca y manejo de la disfuncion sexual masculina.Info
- Publication number
- MX2020013340A MX2020013340A MX2020013340A MX2020013340A MX2020013340A MX 2020013340 A MX2020013340 A MX 2020013340A MX 2020013340 A MX2020013340 A MX 2020013340A MX 2020013340 A MX2020013340 A MX 2020013340A MX 2020013340 A MX2020013340 A MX 2020013340A
- Authority
- MX
- Mexico
- Prior art keywords
- extract
- sexual dysfunction
- composition
- management
- male sexual
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/67—Piperaceae (Pepper family), e.g. Jamaican pepper or kava
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Mycology (AREA)
- Alternative & Traditional Medicine (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Endocrinology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Reproductive Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Gynecology & Obstetrics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN201941006993A IN201941006993A (enExample) | 2019-02-22 | 2019-02-22 | |
| PCT/US2019/027783 WO2020171833A1 (en) | 2019-02-22 | 2019-04-17 | Aphrodisiac composition and management of male sexual dysfunction |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2020013340A true MX2020013340A (es) | 2021-02-02 |
Family
ID=72142598
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2020013340A MX2020013340A (es) | 2019-02-22 | 2019-04-17 | Composicion afrodisiaca y manejo de la disfuncion sexual masculina. |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US10864242B2 (enExample) |
| EP (1) | EP3927360A4 (enExample) |
| JP (1) | JP7717461B2 (enExample) |
| KR (1) | KR102571381B1 (enExample) |
| AU (1) | AU2019430124B2 (enExample) |
| CA (1) | CA3103127A1 (enExample) |
| EA (1) | EA202092760A1 (enExample) |
| IN (1) | IN201941006993A (enExample) |
| MX (1) | MX2020013340A (enExample) |
| WO (1) | WO2020171833A1 (enExample) |
| ZA (1) | ZA202007819B (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IN201941006993A (enExample) * | 2019-02-22 | 2019-03-01 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20010041187A1 (en) * | 1998-10-20 | 2001-11-15 | Carl W Hastings | Performance-enhancing dietary supplement |
| US6866872B1 (en) * | 1999-05-10 | 2005-03-15 | Nippon Shinyaku Co., Ltd. | Withania somnifera Dunal extracts for increasing male sperm count |
| KR100517637B1 (ko) | 2001-12-21 | 2005-09-28 | 씨제이 주식회사 | 섬수 정제 엑스 및 인삼 정제 엑스를 함께 함유하면서다른 정유 생약 성분은 함유하지 않는 조루증의 예방 및치료용 조성물 |
| ITMI20031428A1 (it) * | 2003-07-11 | 2005-01-12 | Indena Spa | Combinazioni di agenti vasoattivi e loro uso per il trattamento di disfunzioni sessuali |
| CA2563952C (en) * | 2004-04-27 | 2016-05-17 | Ramaswamy Rajendran | Uses of the pregnane glycosides in the treatment/management of obesity, obesity-related and other disorders |
| US20060269623A1 (en) | 2005-05-31 | 2006-11-30 | Pierre Swaab | Herbal composition and method of use for promoting erections and treating erectile dysfunction in men |
| US20110064720A1 (en) * | 2009-09-16 | 2011-03-17 | Daniel Moses Amato | Dietary Supplement Compositions and Methods of Making and Using the Same |
| US20190117555A1 (en) * | 2016-03-11 | 2019-04-25 | Harmonic Pharma | Sublingual compositions comprising natural extracts and uses thereof |
| WO2018033892A1 (en) * | 2016-08-19 | 2018-02-22 | Aurea Biolabs Private Limited | A formulation for improving physical endurance in athletes and a method for preparing the samea formulation for improving physical endurance in athletes and a method for preparing the same |
| WO2018220232A1 (en) | 2017-06-02 | 2018-12-06 | Universite De Versailles-St Quentin En Yvelines | Pharmaceutical combination product comprising botulinum toxin for the treatment of erectile dysfunction |
| IN201941006993A (enExample) * | 2019-02-22 | 2019-03-01 |
-
2019
- 2019-02-22 IN IN201941006993A patent/IN201941006993A/en unknown
- 2019-04-17 EA EA202092760A patent/EA202092760A1/ru unknown
- 2019-04-17 CA CA3103127A patent/CA3103127A1/en active Pending
- 2019-04-17 KR KR1020217002561A patent/KR102571381B1/ko active Active
- 2019-04-17 EP EP19916184.5A patent/EP3927360A4/en not_active Withdrawn
- 2019-04-17 US US16/386,376 patent/US10864242B2/en active Active
- 2019-04-17 WO PCT/US2019/027783 patent/WO2020171833A1/en not_active Ceased
- 2019-04-17 JP JP2020569770A patent/JP7717461B2/ja active Active
- 2019-04-17 AU AU2019430124A patent/AU2019430124B2/en active Active
- 2019-04-17 MX MX2020013340A patent/MX2020013340A/es unknown
-
2020
- 2020-12-15 ZA ZA2020/07819A patent/ZA202007819B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ZA202007819B (en) | 2022-12-21 |
| US10864242B2 (en) | 2020-12-15 |
| US20200268822A1 (en) | 2020-08-27 |
| CA3103127A1 (en) | 2020-08-27 |
| EP3927360A4 (en) | 2022-11-16 |
| KR20210024615A (ko) | 2021-03-05 |
| EA202092760A1 (ru) | 2021-12-21 |
| IN201941006993A (enExample) | 2019-03-01 |
| EP3927360A1 (en) | 2021-12-29 |
| JP7717461B2 (ja) | 2025-08-04 |
| AU2019430124A1 (en) | 2021-07-22 |
| AU2019430124B2 (en) | 2023-10-19 |
| BR112020025686A2 (pt) | 2021-08-31 |
| JP2022524665A (ja) | 2022-05-10 |
| WO2020171833A1 (en) | 2020-08-27 |
| KR102571381B1 (ko) | 2023-08-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO2020000145A2 (es) | Carboxamidas como moduladores de los canales de sodio | |
| EA202092490A1 (ru) | Модуляторы метилмодифицирующих ферментов, композиции и их применения | |
| CA3108065C (en) | Spray-dried dispersions, formulations, and polymorphs of (s)-5-amino-3-(4-((5-fluoro-2-methoxybenzamido)methyl)phenyl)-1-(1,1,1-trifluoropropan-2-yl)-1h-pyrazole-4-carboxamide | |
| PH12018502438A1 (en) | Spiro-lactam nmda receptor modulators and uses thereof | |
| MX388786B (es) | Moduladores nmda espiro-lactam y métodos de uso de los mismos. | |
| DK1663244T3 (da) | Pteridin-derivater til behandling af TNF-alpha-beslægtede sygdomme | |
| MX383650B (es) | Moduladores del receptor nmda espiro-lactam y uso de los mismos. | |
| EA202191188A1 (ru) | Бензамиды производных пиразолил-амино-пиримидинила, композиции на их основе и способы применения | |
| ECSP21068097A (es) | Anticuerpos claudina 6 y usos de los mismos | |
| MY200962A (en) | Amide Derivatives As Nav1.7 And Nav1.8 Blockers | |
| MX385336B (es) | Moduladores del receptor nmda espiro-lactam y uso de los mismos. | |
| MX386938B (es) | Moduladores del receptor nmda espiro-lactam y uso de los mismos. | |
| MX391392B (es) | ANILLOS 5-5 FUSIONADOS COMO INHIBIDORES C5a. | |
| EA202092829A1 (ru) | Композиции тофацитиниба с контролируемым высвобождением | |
| MX2023014946A (es) | Composicion farmaceutica para administracion oral que comprende derivado de aminopirimidina o su sal. | |
| MX2022008479A (es) | Combinaciones de brimonidina de dosis baja y usos de las mismas. | |
| BR112018071370A2 (pt) | composições farmacêuticas orais de mesalazina | |
| BR112022004677A2 (pt) | Composição oftálmica para o tratamento de uveíte | |
| MX2020004107A (es) | Tabletas de deferiprona de liberacion retrasada y metodos de uso de las mismas. | |
| MX2021007247A (es) | Derivados de rapamicina. | |
| TR201721505A2 (tr) | Li̇nagli̇pti̇n ve metformi̇n i̇çeren kombi̇nasyon | |
| MX2020011756A (es) | Compuesto farmaceutico, sales del mismo, formulaciones del mismo y metodos para hacer y usar el mismo. | |
| AR118625A1 (es) | Composición cosmética tópica y usos de la misma | |
| MX2020013340A (es) | Composicion afrodisiaca y manejo de la disfuncion sexual masculina. | |
| MA49839B1 (fr) | Inhibiteurs bicycliques de la histone déacétylase |